ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.8M
1-Year Return
57.47%
This Quarter Return
-1.4%
1 Year Return
+57.47%
3 Year Return
+81.9%
5 Year Return
+179.01%
10 Year Return
–
AUM
$2B
AUM Growth
+$231M
(+13%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
12.79%
Top 10 Holdings %
Top 10 Hldgs %
8.34%
Holding
1,933
New
620
Increased
448
Reduced
311
Closed
543
Top Buys
| 1 |
Intel
INTC
|
+$18.3M |
| 2 |
Netflix
NFLX
|
+$15.3M |
| 3 |
EOG Resources
EOG
|
+$11.7M |
| 4 |
Amazon
AMZN
|
+$11.1M |
| 5 |
NVIDIA
NVDA
|
+$10.8M |
Top Sells
| 1 |
Apple
AAPL
|
+$25M |
| 2 |
Herbalife
HLF
|
+$20.8M |
| 3 |
Home Depot
HD
|
+$12.7M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$12.3M |
| 5 |
Booking.com
BKNG
|
+$12.2M |
Sector Composition
| 1 | Consumer Discretionary | 15.88% |
| 2 | Technology | 15.21% |
| 3 | Financials | 12.06% |
| 4 | Industrials | 11.93% |
| 5 | Healthcare | 11.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Coeur Mining
CDE
$9.89B
| $417K | 0.02% |
+86,788
| New | +$417K |
|
927
Element Solutions
ESI
$6.37B
| $417K | 0.02% |
41,000
+14,200
| +53% | +$144K |
|
928
Vertex Pharmaceuticals
VRTX
$102B
| $416K | 0.02% |
2,455
-10,200
| -81% | -$1.73M |
|
|
BBBY
929
Bed Bath & Beyond, Inc.
BBBY
$602M
| $412K | 0.02% |
+47,069
| New | +$412K |
|
|
OPI
930
Office Properties Income Trust
OPI
$21.7M
| $412K | 0.02% |
+13,458
| New | +$412K |
|
931
MGE Energy Inc
MGEE
$3.13B
| $410K | 0.02% |
5,137
+800
| +18% | +$63.9K |
|
932
Valley National Bancorp
VLY
$6.04B
| $410K | 0.02% |
+37,700
| New | +$410K |
|
|
GTS
933
DELISTED
Triple-S Management Corporation
GTS
| $409K | 0.02% |
+30,518
| New | +$409K |
|
|
HR
934
DELISTED
Healthcare Realty Trust Incorporated
HR
| $409K | 0.02% |
+12,208
| New | +$409K |
|
935
Walker & Dunlop
WD
$2.98B
| $408K | 0.02% |
7,297
-4,497
| -38% | -$251K |
|
936
Pilgrim's Pride
PPC
$10.4B
| $407K | 0.02% |
12,700
-35,500
| -74% | -$1.14M |
|
|
CMBT
937
CMB.TECH NV
CMBT
$2.72B
| $407K | 0.02% |
44,210
+600
| +1% | +$5.52K |
|
938
Ingles Markets
IMKTA
$1.31B
| $406K | 0.02% |
+10,441
| New | +$406K |
|
939
KT
KT
$9.67B
| $405K | 0.02% |
+35,804
| New | +$405K |
|
940
Theravance Biopharma
TBPH
$684M
| $405K | 0.02% |
+20,790
| New | +$405K |
|
941
Q2 Holdings
QTWO
$5.19B
| $404K | 0.02% |
+5,120
| New | +$404K |
|
942
Yext
YEXT
$1.06B
| $404K | 0.02% |
25,427
+9,200
| +57% | +$146K |
|
943
Pacira BioSciences
PCRX
$1.21B
| $401K | 0.02% |
10,526
-2,000
| -16% | -$76.2K |
|
944
Core Laboratories
CLB
$595M
| $396K | 0.02% |
8,500
-7,000
| -45% | -$326K |
|
945
Fortive
FTV
$16.8B
| $395K | 0.02% |
6,888
-13,503
| -66% | -$774K |
|
|
WAAS
946
DELISTED
AquaVenture Holdings Limited
WAAS
| $395K | 0.02% |
+20,338
| New | +$395K |
|
947
Canadian Solar
CSIQ
$739M
| $394K | 0.02% |
20,861
-19,300
| -48% | -$365K |
|
948
Axsome Therapeutics
AXSM
$6.12B
| $393K | 0.02% |
+19,428
| New | +$393K |
|
|
CIR
949
DELISTED
CIRCOR International, Inc
CIR
| $391K | 0.02% |
+10,400
| New | +$391K |
|
950
Usana Health Sciences
USNA
$562M
| $390K | 0.02% |
5,696
-15,800
| -74% | -$1.08M |
|